"Amniotic fluid" eye drops aren't approved and could be harmful, the Food and Drug Administration warned.
The emerging field of "cancer chronotherapy" hints that it may be best to receive cancer treatment at a particular time of day.
A study suggests that Black patients might benefit from breast cancer screenings starting at age 42, rather than age 50.
Scientists have developed a new "shape-shifting" antibiotic to fight drug-resistant bacteria, but it hasn't been tested in humans yet.
Health officials have reported 19 confirmed cases and 74 probable cases of blastomycosis linked to a paper mill.
Aging cells undergo a mysterious process called "cryptic transcription," and scientists now think they know why.
A federal judge in Texas has ruled to suspend approval for the abortion pill mifepristone. Here's what you should know about the drug.
The World Health Organization's COVID-19 technical lead is calling for China to release all its data related to the pandemic's origins.
A study of tomato and tobacco plants suggests they emit ultrasonic popping sounds when dehydrated or physically damaged.
Researchers used the AI system AlphaFold to develop a tiny "syringe" that can inject proteins into cells.
Proteins found in tardigrades could be used to stabilize drugs that would otherwise need refrigeration.
A new study estimates that bacteria on meat may be responsible for a significant number of urinary tract infections in the U.S.
A new program will distribute 1 million free at-home HIV tests to U.S. residents and is collaborating with the dating app Grindr to promote the service.
Only a few people have been cured of HIV, but scientists are working to develop cures that could be accessible to more of those infected.
Newly-released genetic data suggests raccoon dogs carrying SARS-CoV-2 may have been at the Huanan Seafood Wholesale Market in late 2019.
A woman who received a stem cell transplant to treat her HIV is still virus-free more than five years after the procedure and 30 months after she stopped taking HIV medication.
A decades-long study finds that many prostate cancer patients can delay aggressive treatments and instead receive "active surveillance."